NCS Multistage Exceeds Guidance with Strong Q4 & Full-Year 2025 Results, Boosted by Operational Gains and Tax Allowance Release

summarizeSummary

NCS Multistage Holdings announced strong fourth quarter and full-year 2025 results, exceeding guidance with significant revenue and profit growth, improved cash flow, and the release of a deferred tax valuation allowance.

check_boxKey Events

• Strong Q4 and Full-Year 2025 Performance

  Total revenues for Q4 2025 reached $50.6 million (up 13% year-over-year) and $183.6 million for the full year (up 13% over 2024), both exceeding the high end of prior guidance. Operating income more than doubled to $10.5 million for the full year, and Adjusted EBITDA increased 20% to $26.7 million.

• Significant Net Income and Tax Benefit

  Net income for Q4 2025 was $15.0 million ($5.34 per diluted share) and $23.7 million ($8.65 per diluted share) for the full year. These figures include a net positive impact of $9.8 million in Q4 and $11.5 million for the full year related to the release of the deferred tax valuation allowance, signaling sustained profitability.

• Improved Cash Flow and Balance Sheet

  The company reported $36.7 million in cash and only $7.6 million in debt as of December 31, 2025. Cash flows from operating activities increased by $9.5 million to $22.2 million, and free cash flow after distributions to non-controlling interest rose by $9.0 million to $18.9 million for the full year.

• Mixed 2026 Market Outlook

  Management anticipates a challenging market environment in 2026, with expected lower customer activity in the U.S. and flat activity in Canada. However, international markets, particularly the Middle East, are projected to see increased activity in the latter half of the year, with the company positioned to outperform underlying trends.

auto_awesomeAnalysis

NCS Multistage Holdings reported robust financial results for Q4 and full-year 2025, significantly surpassing prior guidance. The company demonstrated strong operational leverage, with revenue growth translating into a more than doubling of operating income and a 20% increase in Adjusted EBITDA for the full year. A key highlight is the reversal of a substantial deferred tax valuation allowance, indicating a return to sustained profitability and the ability to utilize deferred tax assets. The company also strengthened its balance sheet with increased cash and free cash flow, providing financial flexibility. While the 2026 outlook anticipates a challenging market with potential declines in U.S. activity, the company expects to outperform through market share gains and international expansion, particularly in the latter half of the year.